jelena jordovic - Infectious Diseases

Author Information

Jelena Jordović is affiliated with the Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, located in Belgrade, Serbia. Her work primarily focuses on infectious diseases, with significant contributions in the study of hepatitis B and C, Clostridium difficile infections, West Nile Virus, and malaria. Her research often explores the efficacy and safety of therapeutic strategies in resource-limited settings, reflecting the challenges and clinical outcomes associated with these infectious diseases.

Research Contributions

Jelena Jordović has made substantial contributions to the field of infectious diseases, particularly concerning chronic viral hepatitis and liver injury. Her research spans the evaluation of therapeutic strategies like pegylated-interferon alpha therapy for hepatitis B and studies on viral response and genotypic predictors in hepatitis C. Additionally, her work includes significant insights into Clostridium difficile infections, the clinical characteristics of imported malaria cases, and the importance of haematological findings in West Nile Virus infections. Her studies often combine clinical experience with comprehensive literature reviews, aiming for practical and effective healthcare solutions in Serbia and similar resource-constrained environments.

Aliases

Jelena Jordović is also known by the alias "Jelena Jordovic".

Publication and Citation Metrics

Metric	Value
Total Papers	10
Total Citations	39
H-index	3

Publications:

Efficacy and safety of pegylated-interferon alpha therapy in patients with chronic hepatitis B in recource-limited settings- Serbian single-center experience

DOI: 10.2298/VSP180727150B

Year: 2020

Uticaj stabilnog virusološkog odgovora na tok i ishod bolesti kod pacijenata sa teškom fibrozom ili cirozom jetre uzrokovanom hroničnom hepatitis C virusnom infekcijom

DOI:

Year: 2020

Micro-elimination of HCV as a possible therapeutic strategy: our experience and a review of literature.

DOI: 10.3855/jidc.11785

Year: 2020

Significance of UGT1A1*28 Genotype in Patients with Advanced Liver Injury Caused By Chronic Hepatitis C

DOI: 10.2478/jomb-2018-0015

Year: 2019

IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injury.

DOI: 10.3855/JIDC.11351

Year: 2019

SIGNIFICANCE OF UGT 1 A 1 * 28 GENOTYPE IN PATIENTS WITH ADVANCED LIVER INJURY CAUSED BY CHRONIC HEPATITIS C ZNA

DOI:

Year: 2018

EFFICACY AND SAFETY OF PEGYLATED-INTERFERON ALPHA THERAPY IN PATIENTS WITH CHRONIC HEPATITIS B IN RECOURCE- LIMITED SETTINGS- SERBIAN SINGLE-CENTER EXPERIENCE EFIKASNOST I SIGURNOST PEGILOVANOG INTERFERONA ALFA- 2A U TERAPIJI HRONIČNOG B VIRUSNOG HEPATITISA- NAŠA ISKUSTVA Authors

DOI:

Year: 2018

Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study

DOI: 10.1007/s10096-017-3169-3

Year: 2017

The Importance of Haematological and Biochemical Findings in Patients with West Nile Virus Neuroinvasive Disease

DOI: 10.1515/jomb-2016-0022

Year: 2016

Clinical characteristics of imported malaria: An 11-year experience in a Serbian referral center.

DOI: 10.3855/jidc.6799

Year: 2016

What are Immunodeficiency Disorders?

What are the complications?

What is a Urinary Tract Infection (UTI)?

What are the clinical features of infections caused by Flaviviridae?

How is HSV Diagnosed?

Are There Different Types of Salmonella?

What is the Role of Healthcare Providers in Managing Infectious Diseases in Pregnancy?

How to Choose the Right Antimalarial Drug?

How Do We Address the Challenge of Antimicrobial Resistance?

What Are the Challenges in Controlling Dengue?

Partnered Content Networks

Relevant Topics